Late Phase Drug Development World Americas 2010
March 23 - 26, 2010(Ended)Hyatt Regency Princeton
Princeton, NJ, United States
Princeton, NJ, United States
Late phase drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency.
As a result, Health Network Communications is delighted to announce the first ever strategic forum in the US addressing the major challenges in conducting strategic and compliant late stage studies.
Venue
Address
102 Carnegie Center, 08540,
Princeton,
New Jersey,
United States
Princeton,
New Jersey,
United States
Prices *
1790-3400 US Dollar
Exhibition
Included
Organization
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Infection Control
- Attending Health conferences is beneficial not only for professionals
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Health conferences
- Chronic lymphocytic leukemia and related disorders - Clinical
- Cochlear Implantation in Auditory Neuropathy
